A Multicenter, Open-label, Phase Ⅲ Study to Evaluate the Efficacy and Safety of Amphotericin B Liposome for Injection in Patients With Persistent Febrile Neutropenia
Latest Information Update: 08 Sep 2023
At a glance
- Drugs Amphotericin B liposomal (Primary)
- Indications Fever; Neutropenia
- Focus Registrational; Therapeutic Use
- Sponsors CSPC ZhongQi Pharmaceutical Technology
- 12 Nov 2021 New trial record